Atlas Trials

Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer

Clinical trial NCT00148707 · COMPLETED

Trial details

NCT number
NCT00148707
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerMetastatic Breast Cancer
Start date
2004-10-01
Primary completion
2007-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.